<DOC>
	<DOCNO>NCT00965328</DOCNO>
	<brief_summary>The low molecular weight heparin nadroparin use anticoagulation extracorporeal hemofiltration circuit . Continuous hemofiltration renal replacement modality intensive care patient acute renal failure . Up know whether nadroparin remove hemofiltration . Accumulation would increase risk bleed . Aim present study determine 1. whether nadroparin accumulates plasma 2. whether nadroparin remove filtration whether removal depend hemofiltration dose 3. effect nadroparin critical illness coagulation anticoagulation</brief_summary>
	<brief_title>Nadroparin Anticoagulation Continuous Venovenous Hemofiltration</brief_title>
	<detailed_description>The low molecular weight heparin ( LMWH ) nadroparin use anticoagulation extracorporeal hemofiltration circuit . LMWH accumulate patient chronic renal failure . Continuous venovenous hemofiltration ( CVVH ) renal replacement modality intensive care patient acute renal failure . Up know whether nadroparin remove hemofiltration . If , accumulation expect risk bleed patient increase . Because critically ill patient increase risk bleeding , question crucial . If nadroparin would remove filtration , removal expect depend hemofiltration dose ( great high dose ) We therefore design randomized control cross-over trial set critical illness acute renal failure compare anticoagulant effect nadroparin ( anti-Xa ) two dos CVVH patient blood , extracorporeal circuit ultrafiltrate . Because hemostasis critically ill patient influenced anticoagulation also critical illness extracorporeal circuit , also measure hemostatic marker , especially endogenous thrombin potential ( ETP ) , seem global marker hemostasis , incorporate procoagulant anticoagulant effect .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Multiple Organ Failure</mesh_term>
	<mesh_term>Nadroparin</mesh_term>
	<criteria>acute renal failure require renal replacement therapy ( recent ) bleed suspicion bleed necessitating transfusion , need therapeutic anticoagulation ( suspect ) heparininduced thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>anticoagulation</keyword>
	<keyword>hemofiltration</keyword>
	<keyword>acute kidney injury</keyword>
	<keyword>heparin</keyword>
	<keyword>hemostasis</keyword>
	<keyword>nadroparin</keyword>
	<keyword>anti-Xa</keyword>
	<keyword>endogenous thrombin potential</keyword>
</DOC>